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Vaginal microbiota differs within individuals and between human populations. Anahtar et al. (2015) iden-
tify a specific vaginal cervicotype commonly found in healthy South African women that causes local-
ized inflammation including activation of antigen-presenting cells and vaginal recruitment of HIV target
cells.Healthy vaginal flora has long been char-
acterized as lactobacillus dominant with
low bacterial diversity and an accompa-
nying low pH. Conversely, ‘‘unhealthy’’
flora is often characterized by high diver-
sity bacterial populations with increased
anaerobic bacteria and lactobacilli pre-
sent at reduced levels (Brotman, 2011).
In the last decade, data from diverse
human populations combined with cul-
ture-independent methods of microbiota
analysis have suggested that this division
is too simplistic. Thus, while lactobacillus
dominance is often associated with
health, the converse might not be neces-
sarily true. What defines a ‘‘healthy’’
vaginal microbiome? Does it depend on
factors such as ethnicities, contraceptive
use, sexual behavior, or all of the above?
Now, a new study by Anahtar et al.
(2015) surveyed a cohort of young healthy
South African women and found that only
a minority (37%) had a lactobacillus-
dominant vaginal microbiota. The women
surveyed fell into four distinct microbiome
clusters or ‘‘cervicotypes;’’ two were
lactobacillus dominant, but the remaining
two were characterized by high bacterial
diversity (Figure 1). Cervicotype 1 (CT1)
is dominated by Lactobacillus crispatus;
CT2 dominated by L. iners; CT3,Gardner-
ella; and CT4 consisting of a complex
mixture of bacteria including Prevotella.
The study found that such cervicotypes
can change over time in a given individual,
but do not depend on sexual behavior
or contraceptive use. Moreover, the
cervicotype was a better predictor of
local inflammatory signature than sexu-
ally transmitted infections (STIs) including
chlamydia and Trichomoniasis, indicating
that localized vaginal inflammation is
controlled at the level of the endogenous
microbiota.790 Immunity 42, May 19, 2015 ª2015 ElseviThe extent of vaginal microbial diver-
sity was demonstrated in an North Amer-
ican study analyzing the vaginal micro-
biota of women of reproductive age
across multiple ethnicities that showed
the presence of five distinct ‘‘community
states.’’ One of these states was repre-
sented by high alpha diversity and low
lactobacillus presence, suggesting that
our concept of the ‘‘normal’’ vaginal mi-
crobiome needs to be reassessed to
include these populations (Ravel et al.,
2011). The high diversity and non-lacto-
bacillus-dominant vaginal community
states are highly represented in African
American and Hispanic populations
(Ravel et al., 2011). Because Anahtar
et al. found a similar high diversity micro-
biome within the same ethnic population,
this raises questions about what deter-
mines the diverse nature of the vaginal
microbiota. In the case of gastrointestinal
microbiota, non-Western diets (Cox and
Blaser, 2013) have been linked to spe-
cific microbial profiles, but it is unclear
whether similar links exist for the vaginal
microbiota.
Bacterial vaginosis (BV) is a relatively
undefined polymicrobial disorder charac-
terized by mix of aerobic and anaerobic
vaginal microbiota—one of the commonly
accepted ways of scoring BV, the Nugent
score, involves analyzing a gram stain for
mixed diversity population (reviewed in
Ma et al., 2012). However a high diversity
vaginal microbiome accompanied by a
high Nugent score might not always be
linked to disease. The study by Anahtar
et al. highlight that of the two cervicotypes
that havehighdiversity, CT3andCT4, only
CT4 is strongly associated with the pres-
ence of inflammatory vaginal cytokines
(Figure 1). Although none of the women
presented with BV symptoms, authorser Inc.found CT4 to be strongly associated with
localized genital inflammation including
increased inflammatory cytokine produc-
tion. Therefore, CT4 might serve as a bet-
ter and more reliable indicator of genital
inflammation than the Nugent score.
This inflammatory cervicotype, CT4, is
not characterized by dominance of a
single genus but is rather composed of
multiple genera including Gardnerella,
Prevotella, Mobiluncus, and Sneathia.
The other high diversity cervicotype,
CT3, is characterized by Gardnerella
dominance but is not significantly associ-
ated with inflammatory cytokines indi-
cating that a single genus, evenGardner-
ella, is not a consistent marker of vaginal
inflammation. The mechanism behind
this has been hard to unravel and is likely
due to multiple microbial and host
interactions. Anahtar et al. shed some
much-needed light on this subject.
In vitro stimulation of immortalized hu-
man vaginal epithelial cells with the bac-
terial isolates representing CT4 induce
higher levels of IL-1a, IL-1b, and IL-8
than L. crispatus (dominant in CT1) or
L. iners (dominant in CT2), indicating
a direct inflammatory consequence of
CT4 bacteria on epithelial cells. The bac-
terial epithelial co-culture data support
previous findings indicating that vaginal
microbes can modulate epithelial cell
responses in a strain-specific manner
(Doerflinger et al., 2014). Further, while
the number of vaginal antigen-presenting
cells (APCs) does not vary with vaginal
microbial populations, the transcriptional
state of these cells is drastically altered in
women with CT4. Gene-expression pat-
terns of vaginal APCs in women with
CT4 overlap with those of LPS-treated
macrophages and DCs, suggesting that
these cells might be directly activated
Figure 1. Vaginal Microbial Composition Influences Inflammation and T Cell Abundance
(Left) Low complexity vaginal flora represented by cervicotype CT1 and CT2 are Lactobacillus dominant
and are not associated with inflammatory cytokine production. (Right) High-diversity vaginal flora, (specif-
ically a cervicotype CT4 enriched formultiple bacterial genera including Prevotella,Sneathia, andGardner-
ella) is strongly correlated with increased inflammatory cytokine production by both epithelial cells and
activated vaginal APCs. These APCs are potentially directly activated by the vaginal microbiota and
secrete both inflammatory cytokines, as well as chemokines resulting in T cell recruitment. Increased
numbers of CCR5+ CD4 T cells in hosts with this cervicotype might explain the previously reported link
between high-diversity vaginal flora and increased HIV susceptibility. Memory CD4 T cells in the female
reproductive tract are often found in close proximity with macrophages in ‘‘memory lymphocyte clusters’’
(Iijima and Iwasaki, 2014). The induction of a localized inflammatorymilieu by high-diversity microbiota will
likely influence the formation of memory lymphocyte clusters and will be an important consideration in the
design of vaccines against STIs, as well as acquisition of HIV-1.
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Previewsby contact with vaginal bacteria. Impor-
tantly, this effect is localized, as the
systemic APCs do not display this inflam-
matory signature.
Women with traditional signs of BV
accompanied by a high Nugent score
have been shown to be at a higher
risk of contracting sexually transmitted
diseases, including HIV-1 and herpes
simplex virus type 2 (HSV-2) (Petrova
et al., 2013). Additionally, increased in-
flammatory cytokines in the cervicovagi-
nal lavage has also been linked with
increased HIV-1 shedding and transmis-
sion (Mitchell et al., 2011). Inflammation-
induced breach in the vaginal epithelial
barrier, recruitment of target cells, and
reduction in antimicrobial peptide secre-
tion have been proposed as mechanisms
for increased susceptibility to STIs. Here,
Anahtar et al. demonstrate that inflamma-
tory cervicotype is also associated with
an increased number of vaginal T cells.They trace this T cell recruitment to
upregulation of chemokine gene expres-
sion by vaginal APCs (Figure 1) thereby
providing a potential mechanism linking
high-diversity vaginal microbiota and
HIV-1 susceptibility. This study suggests
that vaginal APCs are stimulated by
contact with the vaginal resident flora to
upregulate both inflammatory cytokines
and chemokine expression, resulting in
a significant increase in vaginal CCR5+
CD4 T cells. The vaginal mucosa is a
restricted space for lymphocyte migra-
tion including T cells (Shin and Iwasaki,
2013), and a small increase in the number
of accessible target CD4 T cells could
conceivably make a large difference in
HIV-1 infectivity. Conversely, the influ-
ence of microbiota on T cell trafficking
could be important for the formation of
effective mucosal memory in the primary
infections, as well as efficacy of vaccines
against STIs.ImmunityAlthough the microbiota field has made
significant mechanistic advances into
host-commensal dynamics in the gastro-
intestinal tract and the skin, much less is
understood about the vaginal microbiota.
These connections are required before
advances in microbiota-based treatment
and therapy can be made in women’s
health. Anahtar et al. have given us mech-
anistic insight into the ways in which spe-
cific bacterial species might activate
vaginal APCs and recruit T cells into the
vaginal mucosa. Key candidate bacteria
identified in this study can be further
explored in gnotobiotic mice to probe
their causative role in inflammation and
disease susceptibility to STIs. Further,
this study, together with others, now bol-
sters the view that a diverse microbial
community in the vaginal mucosa is asso-
ciated with an inflammatory phenotype
and might serve as a risk factor for HIV-1
acquisition.REFERENCES
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